Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan List, MD
H. Lee Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Oncology Center
Los Angeles, California, United States
Ronald Paquette, MDNot, yet, recruiting - H. Lee Moffitt Cancer Center
Tampa, Florida, United States
Alan List, MDRecruiting - Cleveland Clinic Foundation - Case Western University
Cleveland, Ohio, United States
Jaroslaw P. Maciejewski, MD, PhDRecruiting - Penn State University
Hershey, Pennsylvania, United States
Thomas P. Loughran, Jr., MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2007
- Primary completion
- 28 Feb 2010
- Completion
- 28 Feb 2010
- Last update posted
- 2 Jun 2009
- Registered enrollment
- 54
- Registry id
- NCT00466843
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.